Higher BALF lymphocyte percentage and a CD4/CD8 ratio greater than 1 in BALF lymphocyte subsets were associated with a susceptibility to relapse during treatment of CIP. This evidence concerns the gene CD4 and hereditary sensory and autonomic neuropathy.